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ABSTRACT
Objectives: To adapt a tailored short message service
(SMS) text message smoking cessation intervention
(MiQuit) for use without active health professional
endorsement in routine antenatal care settings, to
estimate ‘real-world’ uptake and test the feasibility of
its use.
Design: Single-site service evaluation.
Setting: A Nottinghamshire (UK) antenatal clinic.
Participants: Pregnant women accessing the
antenatal clinic (N=1750) over 6 months.
Intervention: A single-sheet A5 leaflet provided in the
women’s maternity notes folder describing the MiQuit
text service. Similar materials were left on clinic desks
and noticeboards.
Outcome measures: MiQuit activation requests and
system interactions were logged for two time frames:
6 months (strict) and 8 months (extended). Local
hospital data were used to estimate the denominator of
pregnant smokers exposed to the materials.
Results: During the strict and extended time frames,
13 and 25 activation requests were received,
representing 3% (95% CI 2% to 5%) and 4% (95% CI
3% to 6%) of estimated smokers, respectively. Only 11
(44%) of the 25 requesting activation sent a correctly
formatted initiation text. Of those activating MiQuit, and
invited to complete tailoring questions (used to tailor
support), 6 (67%) completed all 12 questions by text
or website and 5 (56%) texted a quit date to the
system. Of the 11 activating MiQuit, 5 (45%, 95% CI
21% to 72%) stopped the programme prematurely.
Conclusions: A low-intensity, cheap cessation
intervention promoted at very low cost, resulted in a
small but potentially impactful uptake rate by pregnant
smokers.
INTRODUCTION
Prenatal smoking increases the risk of miscar-
riage, stillbirth, preterm birth, low birth
weight, neonatal mortality,1 2 asthma3 and
childhood obesity4 and is estimated to cost
the UK National Health Service (NHS)
between £20 and £87.5 million annually.5
Supporting pregnant women to quit smoking
remains a public health priority.
In England, routine care for pregnant
women identiﬁed as smokers is a referral for
support to Stop Smoking Services for
Pregnant women (SSSP). The SSSP typically
provide face-to-face behavioural support in
combination with nicotine-replacement
therapy with follow-up visits or phone calls.6
However, only around 15% of pregnant
smokers access these.7 Given that the major-
ity of pregnant smokers are interested in
receiving help to quit smoking8 but only a
minority engage with the SSSP, there is an
urgent need to develop new, effective cessa-
tion support options that are sufﬁciently
used by pregnant smokers to confer a public
health beneﬁt.
One potential form of additional cessation
support that could be routinely offered in
antenatal care is self-help. A meta-analysis of
self-help intervention trials found that self-
help almost doubles the chances of abstin-
ence among pregnant smokers compared
with usual care.9 Furthermore, self-help is of
Strengths and limitations of this study
▪ This is the first ‘real-world’ uptake evaluation of
a text message smoking cessation intervention
for pregnant smokers.
▪ The low cost of the promotional materials and
the text message smoking cessation intervention
they promoted mean that even a very small
uptake would likely confer significant public
health impact if intervention effectiveness were
demonstrated.
▪ Estimating the denominator of individuals
exposed to promotional materials in a real-world
context to calculate uptake is challenging and
reliance on routinely collected National Health
Service data may have generated bias.
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high interest to pregnant smokers.8 A delivery medium
showing promise for delivering self-help to pregnant
smokers is text messaging.10 Text messaging is cheap
and could easily reach many pregnant smokers as most
have mobile phones.11 Also, among non-pregnant
smokers, text message-based cessation support is
effective.12
We have developed an individually tailored smoking
cessation text messaging intervention for use in preg-
nancy, called MiQuit; in a small randomised control trial
(RCT) this was found feasible to deliver, acceptable to
pregnant smokers and also, potentially effective.10
While clinical trials can establish the effectiveness of
public health interventions, the impact of an intervention
is a function of its effectiveness multiplied by ‘real-world’
uptake. Therefore, for an intervention such as MiQuit,
which is very unlikely to harm patients, establishing its
likely use should be part of the evaluative process that
determines whether or not a large scale efﬁcacy RCT
should be undertaken. For example, if in ‘real-world’ set-
tings almost no pregnant smokers could be persuaded to
use MiQuit, then an expensive, large RCT would be
unnecessary. However, as MiQuit is so inexpensive to
deliver, if even a small proportion of pregnant smokers
used it, then a large, deﬁnitive RCTwould be much more
justiﬁable as demonstrating even modest efﬁcacy would
likely ensure that MiQuit is judged cost-effective.
Since the feasibility trial,10 we have modiﬁed MiQuit so
that it now should be possible for smokers to initiate this
themselves, without assistance. This modiﬁed MiQuit inter-
vention was made available, without introduction from
health professionals, to all pregnant women attending one
antenatal clinic for antenatal care. In this paper we
describe MiQuit modiﬁcation and distribution processes
and assess the feasibility of women’s ‘self-initiation’ of the
programme which involves their completion of ‘tailoring’
questions via text message or a website. We also estimate
pregnant smokers’ rates of initiating and subsequently can-
celling MiQuit, and evaluate these in the context of preg-
nant smokers’ engagement with local NHS SSSP.
METHODS
Design
This was a single-site service evaluation (King’s Mill
Hospital (KMH), Sherwood Forest Hospitals NHS
Foundation Trust) where initiation and subsequent discon-
tinuation rates for a smoking cessation text message
support system (MiQuit) were recorded among a cohort
of pregnant women. The National Research Ethics Central
Queries Service conﬁrmed that no ethical review was
required as this was a service evaluation. The investigation
was conducted in accordance with the ethical principles
that have their origin in the Declaration of Helsinki, 1996.
Adaptations to MiQuit for use in routine care
The MiQuit text message cessation support system was
initially developed for use within evaluation research
and its original development has been described in
detail elsewhere.10 MiQuit delivers a 12-week advice and
support programme on quitting smoking in pregnancy,
using participant characteristics to tailor the support to
each individual. Most of the support delivered is part of
a structured delivery schedule of either 0, 1 or 2 texts
per day. The frequency of scheduled messages is highest
in the ﬁrst 4 weeks and then reduces for the remainder
of the programme. During the programme, users are
sent two texts enquiring as to whether or not they had
smoked in the previous 3 days (at 3 and 7 weeks).
Responses to these assessment messages are primarily
used to tailor the support subsequently delivered but
they also aim to increase engagement. Additionally,
system users can request support on demand by texting
the system one of two keywords: HELP if they are experi-
encing a craving or temptation to smoke and SLIP if
they have smoked during a quit attempt.
The original system required tailoring characteristics
to be collected by paper questionnaire or telephone
after which researchers initiated the support system
manually. For this study, to ensure MiQuit could be used
in routine care without the need for interpersonal com-
munication, we needed to make two main adaptations to
the initiation procedure (table 1): (1) setting up an
automatic support initiation mechanism that allows indi-
viduals to text a key word (QUIT) plus their ﬁrst name
and current number of weeks of gestation (eg, ‘quit
Katie 13’) to a six-digit shortcode number to initiate
MiQuit support and (2) setting up an automated pro-
cedure for collecting information about each individual
to enable the support to be tailored. To achieve this, we
reduced the number of tailoring characteristics from 26
to 12 to minimise response burden. These 12 character-
istics were those considered of greatest clinical import-
ance that demonstrated sufﬁcient variability in response
to enable support to be meaningfully tailored. These
characteristics included motivation to quit smoking, the
hardest situation to avoid smoking, cessation self-efﬁcacy,
the number of cigarettes smoked per day, time to ﬁrst
cigarette after waking, partner’s smoking status and
reasons for quitting. We set up 12 pairs of automated
‘question-and-response’ text messages that invited users
to text answers to tailoring questions. In case of non-
response, we set up 24 h reminders for each question
with the option to skip a question according to user
preference. In addition, we set up a website (http://
www.miquit.co.uk) to enable all users to complete ques-
tions online if desired and in case they incurred a
charge for sending text messages. We also enabled the
system to ignore any tailoring variable if that variable
was missing and instead use the median response for
that question from the previous feasibility trial.10 As a
consequence, if no tailoring questions are answered the
system delivers entirely generic support, apart from the
use of the individual’s name and weeks of gestation.
Further adaptations were made to increase cessation
support coverage, quality and interactivity (table 1).
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These adaptations were informed by qualitative
studies,13 14 a feasibility trial,10 a smoking cessation-
speciﬁc taxonomy of behaviour change techniques
(BCTs),15 expert consultation and further piloting: (1)
existing messages were mapped onto smoking cessation
BCTs and new messages created where there was low
coverage of BCTs that aligned with MiQuit intervention
objectives; (2) reﬁnements were made to the content of
messages relating to accuracy and quality in response to
feedback from experts in smoking cessation; (3) we
added the keyword QUIZ for on-demand support,
enabling users to play a multiple choice text message
trivia quiz game designed to support distraction from
smoking; (4) at the end of the programme (12 weeks),
an additional smoking status assessment message was
added; (5) a facility for enabling users to increase or
decrease the frequency of support texts at any time was
developed by texting MORE or LESS; (6) we incorpo-
rated the facility for users to text in a quit date to
receive an additional 10-day schedule of text support
orientated around this date, which could be reset at
any time; (7) we added a series of gestation-tailored
baby development information texts sent every 2 weeks
during the programme to promote a mother-orientated
identity and (8) we also added a set of smoking in
pregnancy risk information messages that were only
delivered if the user replied to an invitation prompt
text.
Participants
Pregnant women attending a booking visit with their
community midwife from KMH between January and
September 2013.
Intervention and procedure
All pregnant women in England receive a maternity
notes folder at their ﬁrst ‘booking’ appointment with
their midwife at approximately 8–12 weeks gestation.
These notes are held by the mother throughout her
pregnancy and include her personal maternity records
from all antenatal appointments. A single-sheet A5
leaﬂet describing MiQuit was inserted into 1750 of these
maternity notes folders within the antenatal clinic in
mid-December 2012. Midwifery management indicated
that it would take several weeks before these maternity
notes folders reached circulation. Based on hospital his-
torical data it was estimated that this number of leaﬂets
would cover approximately 6 months of booking
appointments by community midwives. The promotional
leaﬂet was inserted alongside two other health advice
leaﬂets not related to smoking. In addition to providing
information about the support provided and potential
costs associated with activating MiQuit, the leaﬂet
explained how to activate MiQuit support (see online
supplementary material) and how to discontinue text
support. Similar MiQuit information was included on A3
posters placed in the ultrasound clinic area and the
Table 1 Summary of adaptations made to MiQuit for use in ‘real-world’ settings
MiQuit—used in feasibility trial MiQuit—adapted for use in routine care
Initiation procedure
Initiation manually activated by researchers Users text QUIT plus their first name and weeks of gestation
(‘quit Katie 12’) to a six-digit shortcode
Tailoring data (26 characteristics) collected by a paper
questionnaire or completed over the phone
Tailoring data (12 characteristics) collected via automated
multiple choice text message questions or website
Increasing support coverage and quality
N/A Messages mapped onto BCTs appropriate to intervention
objectives. New messages created where coverage was low
N/A Messages were reviewed by two smoking cessation experts
to ensure accuracy and quality of content and refinements
made in response to feedback
Interactivity
On-demand support if users are experiencing a craving to
smoke (text HELP) or if they have smoked during a quit
attempt (text SLIP)
Addition of the keyword QUIZ to play a multiple choice text
message trivia quiz for distraction
Smoking status assessment text messages sent at 3 and
7 weeks into programme to increase engagement and further
tailor the support delivered
Addition of an end of programme (12 weeks) smoking status
assessment text message
N/A Facility created where users can increase or decrease
frequency of support by texting MORE or LESS
N/A Facility created to provide an additional schedule of support
messages if user texts in a quit date
N/A Series of gestation-tailored baby development information
texts
N/A Additional smoking in pregnancy risk information messages
only delivered if user responds to an invitation prompt text
BCTs, behaviour change techniques.
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antenatal ward and promotional ‘banner’ pens and
credit card-sized information cards which were left in
the ultrasound clinic area within the antenatal clinic. As
our intention was to estimate the rate of initiation of
text message support in the absence of health profes-
sionals’ recommendations to do so, maternity staff were
not directly informed about the promotional materials.
Checks were made with maternity managers in March
2013 to ensure promotional materials were made avail-
able as expected.
Initiating MiQuit
After reading the advertising leaﬂet, a woman could ini-
tiate MiQuit by sending a text message to the shortcode
number listed; this text either cost the user their stand-
ard rate for sending text messages (usually between 8
and 12 pence) or was free, depending on their mobile
provider/tariff. All subsequent text messages sent to
MiQuit were sent to a ‘virtual reply number’ (VRN), the
equivalent of sending a text message to a UK mobile
phone. Completion of tailoring questions using the
website was free, unless users were charged by their pro-
vider for internet usage. To discontinue the support at
any stage, users were advised to text STOP to the VRN.
Measures
The outcome measures were estimates of the propor-
tions requesting MiQuit support activation among (1)
pregnant women and (2) pregnant smokers. The pro-
portion of those who activated the programme who sub-
sequently discontinued it prematurely by texting STOP
was also collected, by the MiQuit system. Feasibility mea-
sures included correct use of the incoming activation
request text messages and the number of tailoring ques-
tions completed. General system usage data was also col-
lected. Nicotine dependence was measured using an
adapted version of the Heaviness of Smoking Index,16
collected as part of the tailoring questions.
Rates of access to the local Stop Smoking Service for
Pregnant women (SSSP), Nottinghamshire New Leaf,
were calculated using routinely collected data from the
Hospital Trust and the SSSP. Access was deﬁned as those
pregnant smokers attending at least one smoking cessa-
tion appointment. We collected these data to help assess
the rate of MiQuit activation in the context of rates of
other use of cessation support, without any prior hypoth-
esis that one should affect the other.
Sample size
Using historical data from the KMH, during the
12-month period April 2011 to March 2012, 894 babies
were born to women who had been recorded as
smoking at booking. Therefore, during the 6 months
when MiQuit would be made available, we estimated
that approximately 450 women who smoke would attend
a booking appointment for their pregnancy and receive
a MiQuit promotional leaﬂet. With this sample, an
uptake rate of 5% would be estimated with 95% CIs of
±2% (3% to 7%) and of 10% with 95% CIs of ±3% (7%
to 13%).
A priori, it was decided that MiQuit activation requests
would be monitored only for the 6-month period when
promotional materials were intended to be made avail-
able (‘strict period’). However, a signiﬁcant number of
activation requests occurred during the subsequent
3 months, due most likely to a lag in the booking packs
that contained the materials being handed out by mid-
wives, supplementary materials still in circulation or to
women retaining the materials and taking a short while
to decide to activate MiQuit support. Site visits con-
ﬁrmed that the booking notes folders containing the
MiQuit leaﬂets had all been taken by midwives by
mid-June 2013 and the information cards and pens had
been removed from the antenatal clinic by the begin-
ning of August, but may have been available until then.
Therefore, post hoc, an ‘extended period’ for activations,
potentially reﬂecting a more realistic scenario, was used
for comparison. This used all activation requests
recorded for the period when activations were logged
(approximately 9 months), using an 8-month period
( January–August 2013) as the period of availability of
materials that is, when pregnant women had direct
access to the materials. MiQuit was not promoted
outside of this evaluation and individuals could only sign
up using the shortcode and keyword combination
unique to this study.
Statistical analysis
To estimate the proportion of pregnant women and
pregnant smokers who requested MiQuit support out of
those exposed to promotional materials, we used the
number of activation requests during the two time
periods with equivalent estimated denominators of all
pregnant women and pregnant smokers using KMH
data. Smokers were deﬁned as those reporting smoking
at booking. The proportion of individuals sending an
activation request and discontinuing MiQuit are pre-
sented with 95% CIs using the Wilson score method
without continuity correction due to the small expected
event rate.
To estimate the equivalent SSSP access rate of women
referred from KMH, the number of pregnant smokers
identiﬁed at booking for the whole Trust was divided by
the number of pregnant women who attended an
appointment with the local SSSP who were referred
from the Trust. The proportion of women referred from
KMH out of those from the Trust was then calculated
and applied to calculate the access rate.
RESULTS
For the 6-month ( January–June 2013) and 8-month
( January–August 2013) periods when promotional mate-
rials were available, 1775 and 2356 women, respectively,
were booked for antenatal care with the Kings Mill
Trust. Among the women attending these appointments,
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there were 449 smokers recorded (25.3%) in the
6-month and 585 smokers recorded (24.8%) in the
8-month periods. During the strict 6-month period, 13
activation requests for MiQuit were received represent-
ing 0.7% (95% CI 0.4% to 1.3%) of all pregnant women
and 3% (95% CI 2% to 5%) of those estimated to be
smokers. For the extended 9-month period for activa-
tions, 25 requests were received representing 1.1% (95%
CI 0.7% to 1.6%) of all pregnant women and 4% (95%
CI 3% to 6%) of estimated smokers (table 2).
Of the 25 activation requests received for MiQuit
within the study duration, only 11 (44%) successfully
sent an activation text message which included the
requested information and consequently activated
MiQuit support. Of those who did not send the
requested information, 11 (44%) sent just the keyword
QUIT and 3 (12%) sent QUIT and their name and
weeks of gestation, but in a format that was not readable
by the system.
Of the 11 who activated MiQuit support, 5 (45%, 95%
CI 21% to 72%) discontinued the programme prema-
turely by texting STOP. Two of these individuals texted
STOP shortly after activating the support and the
remaining three, who all indicated that they were cur-
rently smoking in response to the 3-week smoking status
assessment message, stopped the support shortly after-
wards. The timing of the STOP requests from these
three individuals corresponded closely with a scheduled
text message reminding users how to stop the support.
The mean gestation of the 11 individuals who acti-
vated MiQuit support was 15 (SD=9.2) weeks. In terms
of trimester, ﬁve (46%) were in the ﬁrst, four (36%) in
the second and two (18%) in the third trimester. Nine
individuals remained in the programme long enough to
be invited to complete tailoring questions. Six (67%)
completed all tailoring questions, three via text messages
and three via the website. The remaining three indivi-
duals responded to 1, 2 and 8 tailoring questions,
respectively. Five (56%) texted a quit date to MiQuit and
two (22%) increased the intensity of the text message
support with no users decreasing the intensity. Of those
providing sufﬁcient information for calculating nicotine
dependence (n=7), two users (29%) had high depend-
ence, three (43%) had medium and two (29%) users
had low dependence.
Equivalent access rates for the local Stop Smoking
Service for the extended period were 5% (95% CI 4%
to 6%) of all pregnant women and 17% (95% CI 14%
to 19%) of estimated pregnant smokers.
DISCUSSION
When an short message service (SMS) text message
smoking cessation support programme (MiQuit) was
adapted for use in routine care and made available to
all pregnant women in one NHS Trust using a basic
method of promotion without active recommendation
from health professionals, an estimated 3–4% of
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pregnant smokers requested to initiate use. While difﬁ-
culties were experienced in sending the initiation text
message in the correct format, the majority of those who
successfully initiated MiQuit completed all 12 tailoring
questions and almost half texted in a quit date to the
system.
As far as the authors are aware, this is the ﬁrst ‘real-
world’ uptake evaluation of a text message smoking ces-
sation service among smokers and the ﬁrst investigation
of non-routine cessation support uptake among preg-
nant smokers. The investigation provides an estimate of
uptake for a very low-cost promotion of a cessation inter-
vention that can be used without health professional
instruction. We have demonstrated that a signiﬁcant,
though small, minority of pregnant smokers in one site
were sufﬁciently interested in cessation support that they
would activate self-help as a result of unsolicited promo-
tional materials. Requests for MiQuit activation repre-
sent approximately 25% of those attending at least one
face-to-face support consultation with the Stop Smoking
Services. Real-world uptake estimates are valuable as
they can be combined with an effectiveness estimate to
allow a precise calculation of cost-effectiveness, which
can inform commissioning decisions better than efﬁcacy
data alone.17
However, there are challenges with estimating real-world
uptake, including limitations speciﬁc to this evaluation.
A particular challenge was estimating the denominator
of pregnant smokers. Our approach is open to error as
(1) the time periods of the study and the collection of
the smoking data do not correspond exactly and (2) the
hospital data may underestimate the number of preg-
nant smokers who had engaged with maternity care due
to misreporting.18 The latter bias, if present, could have
resulted in an overestimation of the proportion of preg-
nant smokers who requested to initiate MiQuit.
Conversely, both time frame scenarios used may have
underestimated uptake. The ﬁrst scenario did not allow
for all women to delay uptake and the second included
25% of women in the denominator used to calculate
uptake who may not have received the MiQuit leaﬂet, as
their booking appointment was subsequent to all leaﬂets
having been given out in the maternity notes folders. In
rare cases women can be booked within an antenatal
clinic with a booking notes pack from an outside clinic,
which would underestimate uptake further. Another
limitation is the difﬁculty in identifying which promo-
tional materials motivated women to initiate support.
While we consider the leaﬂet to have been the main
source of information, supported by the ﬁndings from a
small number of qualitative interviews undertaken
among those who initiated support, the information
cards, promotional pens and posters may have
accounted for a signiﬁcant proportion of the initiation
requests. Furthermore, midwives may have become
aware of the materials and promoted them directly, as
found in one of the interviews. It is possible that materi-
als placed within the antenatal clinic could have been
seen by women in later pregnancy who might not have
been included in the denominator of pregnant women
because they entered antenatal care prior to January
2013.
We found an uptake rate for MiQuit which is very similar
to that reported for telephone quitlines, viewed as central
to tobacco control policy in countries such as Australia
and the UK. For example, during promotional national
mass media campaigns in Australia and England, access
rates among general smokers for telephone quitlines were
3.6% and 4.2%, respectively.19 20 Unlike the MiQuit
uptake evaluation, not all access to the quitlines would
have been attributable to the mass media campaigns and
some calls would not have resulted in the receipt of formal
smoking cessation support. Nevertheless, this level of
engagement with quitlines is considered an important
public health achievement.19 Recently, a national cam-
paign to promote a self-help ‘Quit Kit’ in England includ-
ing mass media, supermarket and Stop Smoking Services
promotions resulted in an uptake of approximately 5%
when applying a model of smoking behaviour in
England.21 22 The MiQuit uptake rate observed using a
low-intensity approach could be considered to compare
favourably to other more intensive and costly efforts to
promote uptake of cessation support.
If demonstrated to be effective, in line with the effect
estimates from a feasibility trial10 and similar text message
interventions for non-pregnant smokers,12 the low cost of
delivering MiQuit (approximately £3.20 per user based on
trial data plus maintenance costs) and low dissemination
costs to promote it would likely make it highly cost-
effective. Delivering self-help support by text message
could therefore make an important contribution to the
reduction of maternal and infant complications and
disease due to maternal smoking. Lessons learned from
the current investigation include the importance of using
a simple activation procedure given the high rate of activa-
tion failures and the consideration of using fewer than 12
tailoring questions when pregnant smokers initiate com-
pletion of these by text message rather than website.
Compared with a feasibility trial,10 we observed a
markedly higher discontinuation rate (46% vs 9%).
While this is similar to the 44% discontinuation rate of
routine SSSP support, using a deﬁnition of those not
attending a 4-week follow-up appointment,7 these rates
may not be directly comparable given the difference in
the type of support provided, effort required to discon-
tinue them and reasons for doing so. Interestingly the
MiQuit feasibility trial found that only 25% of partici-
pants discontinuing MiQuit support prematurely found
the programme annoying.10 Further insight into rates of
premature discontinuation of text message support in
real-world contexts is therefore required. Of note is that
non-pregnant smokers who discontinue cessation text
message support are found to be more likely to have
engaged in quitting smoking and subsequently relapsed
than not have attempted to quit at all.23 Therefore, it
cannot be assumed that discontinuation reﬂects lack of
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engagement with attempting to quit smoking. When
using SSSP appointment rates to contextualise MiQuit
uptake rates, our estimate of the proportion engaging in
cessation support, 17%, is likely to have been an overesti-
mate. A UK evaluation study of an ‘opt-out’ referral
pathway, a procedure implemented at the KMH during
the evaluation period, found that only 60% of women
attending a smoking cessation appointment set a quit
date; a prerequisite for receiving cessation support.24
Therefore, MiQuit uptake rates may be closer to the
uptake of SSSP support than initially estimated.
Identifying how to optimise promotion and uptake of
self-help interventions like MiQuit are important areas for
future investigation. One important format to compare to
the promotion approach used in this investigation is staff
or health professional endorsement alongside the provi-
sion of promotional materials. Given the demonstration
that unsolicited promotional materials appear sufﬁcient
on their own to generate uptake, the time cost of a health
professional providing a leaﬂet to pregnant smokers would
be low and could potentially increase cost-effectiveness if
uptake was increased. Leaﬂet design is another aspect
which could affect uptake including the use of NHS brand-
ing, which was not used in this investigation. Finally, it is
important to establish whether uptake of text messaging
support might decrease use of other cessation support.
These remain areas for future research.
Conclusion
Adapting a text message cessation service, originally
designed for use in research, for use in routine care was
feasible, and promoting its use without active recommen-
dations from health professionals resulted in 3–4% of esti-
mated pregnant smokers requesting to receive text
message cessation support. Most individuals who initiated
the text message support engaged with the request for
smoking-related information in order to tailor the
support, via text message or website. Almost half chose to
discontinue the text message support before programme
completion. However, further research is required to
better understand the reasons why some recipients of text
support discontinue it prematurely. These ﬁndings suggest
that a large, deﬁnitive trial testing MiQuit efﬁcacy would
be a rational use of resource funds.
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